)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
NanoEcho
NanoEcho (NANECH) investor relations material
NanoEcho Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary12 Feb, 2026
Executive summary
Focused on advancing clinical validation and commercialization of a novel diagnostic system for rectal cancer, aiming to improve patient outcomes and reduce unnecessary surgeries.
Achieved first commercial sale to Lund University, marking initial revenue and a key reference for future expansion.
Completed key clinical milestones, including a successful dose confirmation study and system adaptations for clinical use.
Secured all regulatory and ethical approvals for the upcoming Proof of Concept (PoC) study.
Maintained strict cost control and extended financial runway through efficiency measures and capital raises.
Financial highlights
Q4 2025 net sales: 0 TSEK (0 TSEK Q4 2024); full year: 488 TSEK (0 TSEK 2024), reflecting first system sale.
Net loss after tax: -3,803 TSEK in Q4 (-3,509 TSEK Q4 2024); full year: -15,654 TSEK (-15,146 TSEK 2024).
Cash flow from operations: -2,643 TSEK in Q4 (-1,587 TSEK Q4 2024); full year: -16,163 TSEK (-14,602 TSEK 2024).
Cash and cash equivalents at year-end: 2,127 TSEK (14,651 TSEK prior year).
Equity ratio at year-end: 80% (56% prior year).
Outlook and guidance
PoC study initiated in early 2026, with results to inform future registration studies and market approval.
Ongoing efforts to secure additional funding via a rights issue and EIC Accelerator grant application.
Targeting market approval submission by 2029, contingent on successful clinical milestones and financing.
Capital needs to reach 2029 market approval
Key milestones for registration study initiation
Strategy for early clinical revenue generation
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from NanoEcho
- Product development finalized, ISO certified, and clinical phase initiated after successful financing.NANECH
Q2 202423 Jan 2026 - First commercial sale and improved financials mark progress toward clinical and market milestones.NANECHQ3 202523 Oct 2025
- Clinical milestones reached, losses narrowed, and first revenues expected soon.NANECHQ2 202521 Aug 2025
- Strong equity and clinical progress position NanoEcho for future commercialization.NANECHQ3 202413 Jun 2025
- Clinical milestone achieved and financial base strengthened for rectal cancer diagnostics.NANECHQ1 20255 Jun 2025
- Clinical progress, new financing, and IPO recognition mark NanoEcho's pivotal year.NANECHQ4 20245 Jun 2025
Next NanoEcho earnings date
Q1 202630 Apr, 2026
NanoEcho
Next NanoEcho earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage